Patient Stories & Interviews

FlowWell: What was your biggest struggle in the first month?

The constipation was unbearable. I'm a healthcare professional, so I thought I'd be fine — I knew the medication, I knew the mechanism. But nothing prepared me for going four or five days without a bowel movement. I felt bloated, lethargic, and honestly embarrassed to bring it up with my prescriber.

FW: How did you find FlowWell?

A patient support Facebook group. Someone posted a link to the GLP-1 Gut Fix and said it was the most practical thing they'd read. I downloaded it that night and read it cover to cover. Within 48 hours of following the hydration and fiber protocol, I had my first comfortable day in weeks.

FW: What specific advice made the biggest difference?

The timing of fiber was something I'd never considered. I was eating fiber, but the guide explained when and how to pair it with water and movement. It also introduced me to the idea that GLP-1s slow gastric motility significantly — and that this is manageable once you know what's happening in your body. That framing alone relieved so much of my anxiety.

FW: You lost weight quickly but something felt wrong — tell us about that.

I dropped 22 pounds in the first three months on Mounjaro, which sounded great. But I felt weak — weaker than I'd felt in years. My grip strength was down, I was fatiguing on my walks, and I looked thinner but not better. A friend who's a physio told me I was probably losing muscle alongside the fat, which happens frequently with rapid GLP-1 weight loss if you're not deliberate about protein.

FW: How did the Fiber-Maxxing & Protein Guide help?

It gave me a clear, practical daily protein target based on my weight — not a generic "eat more protein" suggestion. It also explained why GLP-1s suppress appetite in a way that makes it easy to undereat protein specifically, because fatty and processed foods feel satisfying first. Once I understood the mechanism, I was motivated to be strategic. I now hit 140g of protein on most days, even on days when I'm barely hungry.

FW: Any advice for men in particular who are starting GLP-1s?

Don't let your ego tell you that you'll just "figure it out." I spent three months doing it wrong because I assumed my workout and nutrition instincts would carry over. GLP-1 changes the rules. Get educated early — it's much easier to maintain muscle than to rebuild it.

FW: What was the moment you almost gave up?

Week seven. The nausea had eased, but I'd hit a two-week plateau where the scale wasn't moving, I was constipated, and I was genuinely asking myself, "Is this even working?" I was exhausted from managing side effects while teaching full time. My injection day felt like dread, not hope. I started researching whether stopping was okay.

FW: What changed your mind?

I found the "Why Patients Stop GLP-1s" guide at midnight, honestly expecting it to validate my decision to quit. Instead, it named every single thing I was experiencing — the plateau, the fatigue, the emotional burnout — and explained the clinical evidence for why these are temporary. It showed me that week six to eight is the most common dropout window, and that patients who push through it have dramatically better long-term outcomes. I cried reading it. Someone finally understood exactly what I was going through.

FW: Nine months in — what does life look like now?

I've lost 41 pounds. My blood pressure is normal for the first time since my late twenties. I sleep better, I have more energy in the classroom, and my knees don't hurt anymore. I still have the guide saved on my phone. Whenever I have a rough injection day, I re-read the section on why the medication works long-term. It resets me every time.

FW: You came to GLP-1 medications for heart health, not weight loss — can you explain?

I've struggled with obesity most of my adult life, but the reason my cardiologist recommended semaglutide was the SELECT trial data showing a 20% reduction in major cardiovascular events. I have coronary artery disease. My weight was manageable, but my heart risk wasn't. I needed to understand this medication at a clinical level, not just "it helps you lose weight."

FW: How did the Semaglutide Cardiovascular Guide meet that need?

It was the first patient-facing resource I found that actually cited the trial data and explained the mechanisms — the anti-inflammatory effects, the direct cardiac impact, the blood pressure reductions. As someone who spent 30 years reading clinical literature, I was genuinely impressed by the quality. It read like it was written for someone who could handle nuance, which is rare in patient education materials.

FW: What would you tell other patients who are skeptical about GLP-1s?

I understand the skepticism — I had it too. The media coverage is all about Ozempic face and celebrities misusing it for vanity. But the evidence for appropriate patients is genuinely compelling. What FlowWell does well is help you understand whether you're an appropriate candidate and what realistic expectations look like. That education matters enormously for compliance and outcomes.